|
Fluoxetine and Olanzapine
|
|
Symbyax
|
Fluoxetine and Olanzapine Clinical Trials
- The Study of Olanzapine Plus Fluoxetine in Combination for Treatment-Resistant Depression Without Psychotic Features
ClinicalTrials.gov Identifier: NCT00035321 - Completed
Depressive Disorders
- Serotonin Treatment of Cocaine Dependence - 2
ClinicalTrials.gov Identifier: NCT00142779 - Active, not recruiting
Fluoxetine
- Pharmacological Intervention Project (fluoxetine)
ClinicalTrials.gov Identifier: NCT00027378 - Recruiting
Alcoholism
- Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet
ClinicalTrials.gov Identifier: NCT00324051 - Active, not recruiting
Schizophrenia
- Comparing the Effect of Under the Tongue Olanzapine Versus Swallowed Olanzapine on Body Mass Index (A Ratio of Weight to Height)
ClinicalTrials.gov Identifier: NCT00303602 - Active, not recruiting
Schizophrenia; Schizoaffective Disorder; Bipolar Disorder
- Effect of Fluoxetine (Prozac) on Domestic Violence
ClinicalTrials.gov Identifier: NCT00011765 - Active, not recruiting
Domestic Violence
- Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression
ClinicalTrials.gov Identifier: NCT00485771 - Completed
Bipolar Disorder
- Olanzapine Pamoate Depot Versus Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00320489 - Recruiting
Schizophrenia
- Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder
ClinicalTrials.gov Identifier: NCT00088465 - Active, not recruiting
Schizophrenic Disorders
- Study of Fluoxetine in Adults With Autistic Disorder
ClinicalTrials.gov Identifier: NCT00027404 - Active, not recruiting
Autistic Disorder
- A Controlled Study of Olanzapine in Children with Autism
ClinicalTrials.gov Identifier: NCT00057408 - Recruiting
Autistic Disorder
- Optimal Duration of Olanzapine Add-on Therapy in Major Depression
ClinicalTrials.gov Identifier: NCT00568672 - Recruiting
Relapse Rate of a Major Depressive Episode; Safety of Olanzapine in Subjects With Major Depression
- Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00005850 - Active, not recruiting
Anxiety Disorder; Depression; Fatigue; Non-small cell lung cancer
- Effectiveness of Fluoxetine in Young People for the Treatment of Individuals Dually Diagnosed with Major Depressive Disorder and Marijuana Dependence - 1
ClinicalTrials.gov Identifier: NCT00149643 - Recruiting
Depresive Disorder, Major; Marijuana Abuse
- Validation of Multidimensional Assessment of THYmic States (MATHYS): A Study in a Population of Bipolar Patients Treated With Olanzapine
ClinicalTrials.gov Identifier: NCT00259272 - Recruiting
Bipolar Disorder I or II
- Glucose regulation during risperidone and olanzapine treatment
ClinicalTrials.gov Identifier: NCT00006195 - Recruiting
Schizophrenia
- Clinical Trial Testing the Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia
ClinicalTrials.gov Identifier: NCT00115804 - Recruiting
Juvenile Primary Fibromyalgia Syndrome (JPFS); Fibromyalgia
- A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder (IED)
ClinicalTrials.gov Identifier: NCT00078754 - Recruiting
Intermittent Explosive Disorder
- Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?
ClinicalTrials.gov Identifier: NCT00208897 - Active, not recruiting
Major Depressive Disorder
- Effectiveness of Early Intervention With Fluoxetine in Enhancing Developmental Processes in Children With Autism (STAART Study 2)
ClinicalTrials.gov Identifier: NCT00183339 - Active, not recruiting
Autistic Disorder
- Comparison of Clozapine or Olanzapine in Childhood-Onset Psychotic Disorders
ClinicalTrials.gov Identifier: NCT00001656 - Active, not recruiting
Mental Disorder Diagnosed in Childhood; Psychotic Disorder; Schizophrenia
- Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal Disease
ClinicalTrials.gov Identifier: NCT00573547 - Active, not recruiting
Depression
- Subcutaneous Olanzapine for Hyperactive or Mixed Delirium
ClinicalTrials.gov Identifier: NCT00512291 - Active, not recruiting
Advanced Cancer
- Pfizer/IVGTT/Ziprasidone/Olanzapine
ClinicalTrials.gov Identifier: NCT00205725 - Active, not recruiting
Schizophrenia; Type 2 Diabetes Mellitus
- Study of Fluoxetine in Autism
ClinicalTrials.gov Identifier: NCT00515320 - Recruiting
Autistic Spectrum Disorder
- Determining the Safety and Effectiveness of Olanzapine in Children and Adolescents
ClinicalTrials.gov Identifier: NCT00183612 - Active, not recruiting
Bipolar Disorder; Psychotic Disorders
- Assessing Fibromyalgia Treatments
ClinicalTrials.gov Identifier: NCT00000428 - Active, not recruiting
Fibromyalgia
- A Study of Treatment Success in Changing From Olanzapine to Long-Acting Injectable Risperidone (RISPERDAL® CONSTA™)
ClinicalTrials.gov Identifier: NCT00216632 - Active, not recruiting
Psychotic Disorders; Schizophrenia
- Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in the Maintenance Therapy of Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00088491 - Completed
Schizophrenic Disorders
- Double-Blind Trial of Olanzapine in Patients with Manic or Mixed Episode of Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00129220 - Recruiting
Manic or mixed episode associated with bipolar I disorder
- Treatment of Childhood Social Phobia
ClinicalTrials.gov Identifier: NCT00043537 - Active, not recruiting
Phobic Disorders
- Randomized Study of Fluoxetine in Children and Adolescents With Autism
ClinicalTrials.gov Identifier: NCT00004486 - Completed
Autism
- Drug Treatment for Depressed Alcoholics (naltrexone/fluoxetine)
ClinicalTrials.gov Identifier: NCT00006204 - Completed
Alcoholism; Depression
- Fluoxetine for Anxious Children
ClinicalTrials.gov Identifier: NCT00000381 - Completed
Anxiety Disorders
- The Effect of a Weight Management Program During Treatment With Olanzapine
ClinicalTrials.gov Identifier: NCT00169702 - Recruiting
Schizophrenia
- Short Term Rescue Study of Olanzapine
ClinicalTrials.gov Identifier: NCT00186017 - Recruiting
Bipolar Disorders
- An Evaluation of Divalproex Vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder
ClinicalTrials.gov Identifier: NCT00221481 - Active, not recruiting
Bipolar Disorder
- Relapse Prevention for Bipolar Type-II Disorder
ClinicalTrials.gov Identifier: NCT00044616 - Active, not recruiting
Bipolar Disorder; Depression
- Atomoxetine for Treatment of Weight Gain in Olanzapine or Clozapine Patients
ClinicalTrials.gov Identifier: NCT00176436 - Recruiting
Schizophrenia
- Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers
ClinicalTrials.gov Identifier: NCT00018174 - Completed
Smoking; Depression
- 3 Fixed Dosages of Extended Release OROS Paliperidone and Olanzapine in the Treatment of Subjects with Schizophrenia
ClinicalTrials.gov Identifier: NCT00078039 - Active, not recruiting
Schizophrenia
- Extended Release OROS Paliperidone in Treatment of Schizophrenia (double blind, placebo-controlled trial, with Olanzapine arm)
ClinicalTrials.gov Identifier: NCT00083668 - Active, not recruiting
Schizophrenia
- Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine
ClinicalTrials.gov Identifier: NCT00401973 - Recruiting
Schizophrenia; Schizoaffective Disorders
- Study Comparing Patients Taking Olanzapine and Patients Taking Aripiprazole on Learning of Vocational Skills
ClinicalTrials.gov Identifier: NCT00223418 - Active, not recruiting
Schizophenia Disorder; Schizoaffective Disorder
- Fluoxetine as a Quit Smoking AID for Depression Prone
ClinicalTrials.gov Identifier: NCT00113737 - Completed
Cardiovascular Diseases; Heart Diseases
- Treatment and Outcome of Early Onset Bipolar Disorder
ClinicalTrials.gov Identifier: NCT00048802 - Active, not recruiting
Bipolar Disorder
- Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism
ClinicalTrials.gov Identifier: NCT00449007 - Recruiting
Depression; Alcoholism; Suicidal Behavior
- Treatment of Obsessive-Compulsive Disorder
ClinicalTrials.gov Identifier: NCT00000373 - Completed
Obsessive-Compulsive Disorder
- Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism
ClinicalTrials.gov Identifier: NCT00287820 - Recruiting
Schizophrenia; Diabetes; Metabolic Syndrome; Hyperglycemia
- Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
ClinicalTrials.gov Identifier: NCT00036088 - Completed
Schizophrenia
- Olanzapine versus Placebo in the Treatment of Adolescents with Schizophrenia
ClinicalTrials.gov Identifier: NCT00051298 - Completed
Schizophrenia
- Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Risperidone and Olanzapine.
ClinicalTrials.gov Identifier: NCT00149955 - Recruiting
Schizophrenia; Dual Diagnosis; Schizoaffective Disorder; Psychotic Disorder; Substance Abuse; Cannabis Abuse
- Energy Homoeostasis Under Treatment with Atypical Antipsychotics
ClinicalTrials.gov Identifier: NCT00148564 - Recruiting
Schizophrenia
- Olanzapine Treatment of Patients With Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00510146 - Recruiting
Depression, Bipolar
- An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.
ClinicalTrials.gov Identifier: NCT00510211 - Recruiting
Schizophrenia; Bipolar Disorder
- Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients with Schizophrenia and Schizoaffective Disorder
ClinicalTrials.gov Identifier: NCT00090012 - Completed
Schizophrenia
- An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients
ClinicalTrials.gov Identifier: NCT00520507 - Recruiting
Bipolar Disorder, Depression; Depressive Disorder, Major
- Substance Dependent Teens - Impact of Treating Depression Study 1 - 1
ClinicalTrials.gov Identifier: NCT00061113 - Active, not recruiting
Alcohol-Related Disorders; Marijuana Abuse; Substance-Related Disorders
- BMI and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine.
ClinicalTrials.gov Identifier: NCT00312598 - Recruiting
Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder; Mood Disorders With Psychotic Features
- Treating Drug-Resistant Childhood Schizophrenia
ClinicalTrials.gov Identifier: NCT00048828 - Recruiting
Schizophrenia
- Switching Medication to Treat Schizophrenia
ClinicalTrials.gov Identifier: NCT00044655 - Recruiting
Schizophrenia
- Study of Amantadine for Weight Stabilization During Olanzapine Treatment
ClinicalTrials.gov Identifier: NCT00287352 - Recruiting
Psychotic Disorder; Schizophreniform Disorder; Schizophrenia; Schizoaffective Disorder
- Olanzapine versus Aripiprazole in the Treatment of Acutely Ill Patients with Schizophrenia
ClinicalTrials.gov Identifier: NCT00103571 - Completed
Schizophrenia
- Hypericum vs Fluoxetine for Mild to Moderate Adolescent Depression
ClinicalTrials.gov Identifier: NCT00557427 - Not yet recruiting
Depression
- Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms
ClinicalTrials.gov Identifier: NCT00578669 - Not yet recruiting
Major Depressive Disorder; Nicotine Dependence; Depression
- 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the First 6-Month Trial.
ClinicalTrials.gov Identifier: NCT00174265 - Recruiting
Schizophrenia
- 6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the First 6-Month Trial
ClinicalTrials.gov Identifier: NCT00265343 - Recruiting
Schizophrenia
- Study to Examine the Effect of Betahistine on Body Weight Gain Due to Olanzapine Treatment
ClinicalTrials.gov Identifier: NCT00428168 - Recruiting
Weight Gain
- Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features
ClinicalTrials.gov Identifier: NCT00202293 - Recruiting
Bipolar Disorder; Schizoaffective Disorder
- Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00034580 - Completed
Bipolar Disorder
- Schizophrenia Risperidone vs Olanzapine Study HGMN
ClinicalTrials.gov Identifier: NCT00373321 - Recruiting
Schizophrenia; Schizoaffective Disorder; Schizophreniform Disorder
- Olanzapine Versus Placebo in the Treatment of Mania in Adolescents with Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00050206 - Completed
Bipolar Disorder
- Study Comparing Olanzapine with Haloperidol for the Relief of Nausea and Vomitting in Patients with Advanced Cancer
ClinicalTrials.gov Identifier: NCT00124930 - Recruiting
Refractory Nausea
- Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine
ClinicalTrials.gov Identifier: NCT00512070 - Recruiting
Schizophrenia; Schizoaffective Disorder; Obesity; Metabolic Syndrome
- Study of Olanzapine vs. Aripiprazole in the Treatment of Schizophrenia
ClinicalTrials.gov Identifier: NCT00088049 - Completed
Schizophrenia
- Olanzapine Augmentation Therapy in Treatment-Resistant Depression: a Double-Blind Placebo-Controlled Trial
ClinicalTrials.gov Identifier: NCT00273624 - Recruiting
Therapy-Resistant Depression
- Fluoxetine in Pediatric Body Dysmorphic Disorder
ClinicalTrials.gov Identifier: NCT00245635 - Recruiting
Body Dysmorphic Disorder
- Comparison of Intramuscular Olanzapine Depot with Placebo in the Treatment of Patients with Schizophrenia
ClinicalTrials.gov Identifier: NCT00088478 - Completed
Schizophrenia
- Olanzapine in the Treatment of Patients With Anorexia Nervosa
ClinicalTrials.gov Identifier: NCT00260962 - Recruiting
Anorexia Nervosa
- Olanzapine Compared to Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated with Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00094549 - Completed
Bipolar Disorder
- A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients
ClinicalTrials.gov Identifier: NCT00402324 - Recruiting
Bipolar I Disorder
- Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)
ClinicalTrials.gov Identifier: NCT00000379 - Completed
Stress Disorders, Post-Traumatic
- Safety Study of Olanzapine and a Comparator in Patients With Schizophrenia and Schizoaffective Disorder
ClinicalTrials.gov Identifier: NCT00190749 - Recruiting
Schizophrenia; Schizoaffective Disorder
- Study of Fluoxetine in Patients with Depersonalization Disorder
ClinicalTrials.gov Identifier: NCT00004446 - Completed
Depersonalization Disorder
- PET Imaging and Olanzapine Treatment in Borderline Personality Disorder
ClinicalTrials.gov Identifier: NCT00275301 - Recruiting
Borderline Personality Disorder
- Pilot Study of Topiramate and Olanzapine in the Prevention of Weight Gain in Children and Adolescents With Bipolar Disorder
ClinicalTrials.gov Identifier: NCT00394095 - Recruiting
Bipolar Disorder; Weight Gain
- Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia
ClinicalTrials.gov Identifier: NCT00034801 - Completed
Depression; Schizophrenia; Schizoaffective Disorder
- Medication Treatment for Psychotic Depression
ClinicalTrials.gov Identifier: NCT00056472 - Recruiting
Depression; Major Depressive Disorder
- Population Pharmacokinetic Study in Adolescent Patients with Schizophrenia or Bipolar I Disorder with Olanzapine
ClinicalTrials.gov Identifier: NCT00113594 - Completed
Schizophrenia; Bipolar Disorder
- Efficacy and Safety of Olanzapine in Patients with Borderline Personality Disorder
ClinicalTrials.gov Identifier: NCT00088036 - Completed
Borderline Personality Disorder
- Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder
ClinicalTrials.gov Identifier: NCT00100776 - Completed
Schizophrenia; Schizoaffective Disorder
- The Effects on Thinking of Risperidone and Olanzapine
ClinicalTrials.gov Identifier: NCT00108368 - Completed
Schizophrenia; Psychotic Disorders
- Clinical Trial of Fluoxetine in Anxiety and Depression in Children, and Associated Brain Changes
ClinicalTrials.gov Identifier: NCT00018057 - Recruiting
Depression; Mood Disorder; Anxiety Disorder; Healthy
- Efficacy and Safety of Olanzapine in the Extended Treatment for Manic or Mixed Episode of Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00266630 - Recruiting
Manic or Mixed Episode Associated With Bipolar I Disorder
- Olanzapine in Patients With Advanced Cancer and Weight Loss
ClinicalTrials.gov Identifier: NCT00489593 - Recruiting
Advanced Cancer; Weight Loss
- Olanzapine in Patients with Borderline Personality Disorder
ClinicalTrials.gov Identifier: NCT00091650 - Completed
Borderline Personality Disorder
- A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain
ClinicalTrials.gov Identifier: NCT00363376 - Not yet recruiting
Weight Gain
- Pharmacokinetic Characterization of Intramuscular Olanzapine Depot
ClinicalTrials.gov Identifier: NCT00094640 - Completed
Schizophrenia; Schizoaffective Disorder
- To Determine If Olanzapine Is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia
ClinicalTrials.gov Identifier: NCT00007774 - Completed
Schizophrenia; Schizoaffective Disorder
- Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects during the Maintenance Phase of Bipolar Illness
ClinicalTrials.gov Identifier: NCT00071253 - Terminated
Bipolar Disorder
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
